Understanding key trends transforming pharma commercial model design

The healthcare landscape continues to evolve. Consolidation is shifting the dynamics of influence in numerous ways in different parts of the country. We will examine the different ways pharmaceutical companies are approaching these new dynamics and evolving their commercial model design to maximize performance. These approaches include:

• Impact consolidation is transforming payers and PBMs.
• Localization and value it can create for pharma.
• Evolution of IDN teams and how it impacts commercial model.